These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 32056049)

  • 1. Influenza and antiviral resistance: an overview.
    Lampejo T
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1201-1208. PubMed ID: 32056049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment with baloxavir marboxil of a patient with peramivir-resistant influenza A/H3N2 with a dual E119D/R292K substitution after allogeneic hematopoietic cell transplantation: a case report.
    Harada N; Shibata W; Koh H; Takashita E; Fujisaki S; Okamura H; Nanno S; Yamada K; Nakamae H; Hino M; Kakeya H
    BMC Infect Dis; 2020 Jul; 20(1):478. PubMed ID: 32631240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced Susceptibility to Neuraminidase Inhibitors in Influenza B Isolate, Canada.
    Abed Y; Fage C; Lagüe P; Carbonneau J; Papenburg J; Vinh DC; Boivin G
    Emerg Infect Dis; 2019 Apr; 25(4):838-840. PubMed ID: 30882323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance for antiviral resistance.
    Zambon MC
    Influenza Other Respir Viruses; 2013 Jan; 7 Suppl 1(Suppl 1):37-43. PubMed ID: 23279895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuraminidase inhibitor resistance in influenza: a clinical perspective.
    Lee N; Hurt AC
    Curr Opin Infect Dis; 2018 Dec; 31(6):520-526. PubMed ID: 30299356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors.
    Hatakeyama S; Sugaya N; Ito M; Yamazaki M; Ichikawa M; Kimura K; Kiso M; Shimizu H; Kawakami C; Koike K; Mitamura K; Kawaoka Y
    JAMA; 2007 Apr; 297(13):1435-42. PubMed ID: 17405969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baloxavir marboxil (Xofluza) for treatment of influenza.
    Med Lett Drugs Ther; 2018 Dec; 60(1561):193-196. PubMed ID: 30653474
    [No Abstract]   [Full Text] [Related]  

  • 8. Influenza virus susceptibility and resistance to oseltamivir.
    Aoki FY; Boivin G; Roberts N
    Antivir Ther; 2007; 12(4 Pt B):603-16. PubMed ID: 17944268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
    Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
    Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza.
    Huang CT; Hung CY; Hseih YC; Chang CS; Velu AB; He YC; Huang YL; Chen TA; Chen TC; Lin CY; Lin YC; Shih SR; Dutta A
    Phytomedicine; 2019 Nov; 64():152904. PubMed ID: 31454654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peramivir susceptibilities of recombinant influenza A and B variants selected with various neuraminidase inhibitors.
    Fage C; Tu V; Carbonneau J; Abed Y; Boivin G
    Antivir Ther; 2017; 22(8):711-716. PubMed ID: 29082897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of drug-resistant influenza virus from immunocompromised patients: a case series.
    Ison MG; Gubareva LV; Atmar RL; Treanor J; Hayden FG
    J Infect Dis; 2006 Mar; 193(6):760-4. PubMed ID: 16479508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer.
    Carr S; Ilyushina NA; Franks J; Adderson EE; Caniza M; Govorkova EA; Webster RG
    Pediatr Infect Dis J; 2011 Apr; 30(4):284-8. PubMed ID: 21048522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peramivir. A new and potent neuraminidase inhibitor for the treatment of influenza].
    Reina J
    Rev Esp Quimioter; 2006 Dec; 19(4):317-22. PubMed ID: 17235399
    [No Abstract]   [Full Text] [Related]  

  • 15. Influenza antiviral resistance in the Asia-Pacific region during 2011.
    Leang SK; Deng YM; Shaw R; Caldwell N; Iannello P; Komadina N; Buchy P; Chittaganpitch M; Dwyer DE; Fagan P; Gourinat AC; Hammill F; Horwood PF; Huang QS; Ip PK; Jennings L; Kesson A; Kok T; Kool JL; Levy A; Lin C; Lindsay K; Osman O; Papadakis G; Rahnamal F; Rawlinson W; Redden C; Ridgway J; Sam IC; Svobodova S; Tandoc A; Wickramasinghe G; Williamson J; Wilson N; Yusof MA; Kelso A; Barr IG; Hurt AC
    Antiviral Res; 2013 Feb; 97(2):206-10. PubMed ID: 23274624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virological surveillance and antiviral resistance of human influenza virus in Argentina, 2005-2008.
    Pontoriero A; Baumeister E; Campos AM; Savy VL
    Rev Panam Salud Publica; 2011 Dec; 30(6):634-40. PubMed ID: 22358415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro neuraminidase inhibitory concentration (IC
    Ikematsu H; Kawai N; Tani N; Chong Y; Bando T; Iwaki N; Kashiwagi S
    J Infect Chemother; 2020 Aug; 26(8):775-779. PubMed ID: 32249161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing antiviral therapy for influenza: understanding the evidence.
    Ison MG
    Expert Rev Anti Infect Ther; 2015 Apr; 13(4):417-25. PubMed ID: 25695406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuraminidase inhibitor susceptibility profile of human influenza viruses during the 2016-2017 influenza season in Mainland China.
    Huang W; Cheng Y; Li X; Tan M; Wei H; Zhao X; Xiao N; Dong J; Wang D
    J Infect Chemother; 2018 Sep; 24(9):729-733. PubMed ID: 29866491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effect of sodium baicalin on oseltamivir-resistant influenza A virus via reduction of neuraminidase activity.
    Jin J; Chen Y; Wang D; Ma L; Guo M; Zhou C; Dou J
    Arch Pharm Res; 2018 Jun; 41(6):664-676. PubMed ID: 29572682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.